New York, NY, United States of America

David L Krohn

This inventor holds 1 USPTO granted patent. Top assignee: National Patent Development Corporation. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David L Krohn. Retrieved from https://idiyas.com/inventor/david-l-krohn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David L. Krohn

Introduction

David L. Krohn is an accomplished inventor based in New York, NY. He has made significant contributions to the field of ophthalmology through his innovative patent. His work focuses on developing effective formulations for eye care, showcasing his dedication to improving health outcomes.

Latest Patents

David L. Krohn holds a patent for an ophthalmic formulation. This formulation consists of water, a solid water-soluble polymer of controlled molecular weight, and a medicament or therapeutic agent such as pilocarpine in its pharmacologically acceptable salts. This invention aims to enhance the delivery and effectiveness of treatments for eye conditions.

Career Highlights

Krohn is associated with the National Patent Development Corporation, where he applies his expertise in developing innovative solutions. His work has contributed to advancements in medical formulations, particularly in ophthalmology. His dedication to research and development has positioned him as a notable figure in his field.

Collaborations

David L. Krohn has collaborated with Samuel H. Ronel, further enhancing the impact of his work in the industry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in patent development.

Conclusion

David L. Krohn's contributions to ophthalmic formulations highlight his innovative spirit and commitment to improving healthcare. His patent reflects a significant advancement in the field, showcasing the potential for further developments in eye care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…